Literature DB >> 34604342

Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.

Ke Sun1, Qionghong Xie1, Chuan-Ming Hao1,2.   

Abstract

BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is a histologic pattern characterized by focal glomerular scarring, which often progresses to systemic and diffuse glomerulosclerosis. Previous studies have emphasized that the initiation of classic FSGS occurs in podocytes. The dysfunction and loss of podocytes have been associated with the development of proteinuria and the progression of various diseases. In addition, primary, secondary, and genetic FSGS are caused by different mechanisms of podocyte injury.
SUMMARY: The potential sources and mechanism of podocyte supplementation are the focus of our current research. Increasing attention has been paid to the role played by parietal epithelial cells (PECs) during the progression of FSGS. PECs are not only the primary influencing factors in glomerulosclerosis lesions but also have repair abilities, which remain a focus of debate. Notably, other resident glomerular cells also play significant roles in the progression of this disease. KEY MESSAGE: In this review, we focus on the mechanism of scarring in FSGS and discuss current and potential therapeutic strategies.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Focal segmental glomerulosclerosis; Parietal epithelial cells; Podocytes; Therapeutic strategies

Year:  2021        PMID: 34604342      PMCID: PMC8443927          DOI: 10.1159/000517108

Source DB:  PubMed          Journal:  Kidney Dis (Basel)        ISSN: 2296-9357


  72 in total

1.  Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis.

Authors:  Bart Smeets; Christoph Kuppe; Eva-Maria Sicking; Astrid Fuss; Peggy Jirak; Toin H van Kuppevelt; Karlhans Endlich; Jack F M Wetzels; Hermann-Josef Gröne; Jürgen Floege; Marcus J Moeller
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

2.  Experimental concerns regarding suPAR-related proteinuria.

Authors:  Laurent Mesnard; Yosu Luque; Eric Rondeau
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

Review 3.  Familial FSGS.

Authors:  Martin R Pollak
Journal:  Adv Chronic Kidney Dis       Date:  2014-09       Impact factor: 3.620

4.  A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.

Authors:  Marianne Delville; Tara K Sigdel; Changli Wei; Jing Li; Szu-Chuan Hsieh; Alessia Fornoni; George W Burke; Patrick Bruneval; Maarten Naesens; Annette Jackson; Nada Alachkar; Guillaume Canaud; Christophe Legendre; Dany Anglicheau; Jochen Reiser; Minnie M Sarwal
Journal:  Sci Transl Med       Date:  2014-10-01       Impact factor: 17.956

Review 5.  Leveraging melanocortin pathways to treat glomerular diseases.

Authors:  Rujun Gong
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

6.  Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.

Authors:  Luca Dello Strologo; Isabella Guzzo; Chiara Laurenzi; Marina Vivarelli; Angelica Parodi; Giancarlo Barbano; Roberta Camilla; Floriana Scozzola; Alessandro Amore; Fabrizio Ginevri; Luisa Murer
Journal:  Transplantation       Date:  2009-08-15       Impact factor: 4.939

7.  Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via αvβ6 integrin signaling.

Authors:  Haili Zhu; Jinlin Liao; Xianke Zhou; Xue Hong; Dongyan Song; Fan Fan Hou; Youhua Liu; Haiyan Fu
Journal:  Kidney Int       Date:  2020-02-17       Impact factor: 10.612

8.  The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression.

Authors:  Hélène Lazareth; Carole Henique; Olivia Lenoir; Victor G Puelles; Martin Flamant; Guillaume Bollée; Cécile Fligny; Marine Camus; Lea Guyonnet; Corinne Millien; François Gaillard; Anna Chipont; Blaise Robin; Sylvie Fabrega; Neeraj Dhaun; Eric Camerer; Oliver Kretz; Florian Grahammer; Fabian Braun; Tobias B Huber; Dominique Nochy; Chantal Mandet; Patrick Bruneval; Laurent Mesnard; Eric Thervet; Alexandre Karras; François Le Naour; Eric Rubinstein; Claude Boucheix; Antigoni Alexandrou; Marcus J Moeller; Cédric Bouzigues; Pierre-Louis Tharaux
Journal:  Nat Commun       Date:  2019-07-24       Impact factor: 14.919

9.  ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.

Authors:  Shazia Ashraf; Heon Yung Gee; Stephanie Woerner; Letian X Xie; Virginia Vega-Warner; Svjetlana Lovric; Humphrey Fang; Xuewen Song; Daniel C Cattran; Carmen Avila-Casado; Andrew D Paterson; Patrick Nitschké; Christine Bole-Feysot; Pierre Cochat; Julian Esteve-Rudd; Birgit Haberberger; Susan J Allen; Weibin Zhou; Rannar Airik; Edgar A Otto; Moumita Barua; Mohamed H Al-Hamed; Jameela A Kari; Jonathan Evans; Agnieszka Bierzynska; Moin A Saleem; Detlef Böckenhauer; Robert Kleta; Sherif El Desoky; Duygu O Hacihamdioglu; Faysal Gok; Joseph Washburn; Roger C Wiggins; Murim Choi; Richard P Lifton; Shawn Levy; Zhe Han; Leonardo Salviati; Holger Prokisch; David S Williams; Martin Pollak; Catherine F Clarke; York Pei; Corinne Antignac; Friedhelm Hildebrandt
Journal:  J Clin Invest       Date:  2013-11-25       Impact factor: 14.808

Review 10.  Viruses and collapsing glomerulopathy: a brief critical review.

Authors:  Preeti Chandra; Jeffrey B Kopp
Journal:  Clin Kidney J       Date:  2012-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.